Vitamin D and the VDR gene

Vitamin D is one of the most tested and most supplemented nutrients in the world. Yet a blood level alone can be misleading, because what matters is how strongly that vitamin D acts once it arrives.

Vitamin D works through a receptor

Vitamin D does its job by binding the vitamin-D receptor (VDR) inside your cells, which then switches on hundreds of genes affecting bone, immunity and more. The receptor is the gateway: if it responds weakly, even a “normal” blood level delivers a weaker effect.

VDR variants change the response

Common VDR polymorphisms alter how efficiently the receptor responds to vitamin D. Reduced-response genotypes effectively need a higher vitamin D level to achieve the same biological action as someone with a fully responsive receptor.

Why it matters

Vitamin D influences bone strength, immune function and mood. Two people with identical lab values can be optimally and sub-optimally supplied at the same time, simply because their receptors differ. A genotype reframes the target.

What actually helps

The practical approach is a personalised vitamin D3 dose informed by genotype and confirmed with blood testing, ideally paired with vitamin K2 to direct calcium correctly. The gene sets the target; the test tracks whether you have hit it.

The science, in depth

VDR polymorphisms (such as those tagged by FokI, BsmI, TaqI and ApaI sites) modulate receptor expression and transcriptional activity, shifting the dose-response relationship between circulating 25(OH)D and downstream VDR-mediated effects, which is the rationale for genotype-personalised dosing.